Gonadotropin treatment for infertility - [Medication] - Quest Diagnostics Patient Health Library Gonadotropin treatment for infertility Examples Brand Name Chemical Name Repronex, Humegon, Pergonal, Metrodin, Bravelle human menopausal gonadotropin (hMG) Gonal-F, Follistim recombinant human follicle-stimulating hormone (rFSH) A.P.L., Pregnyl, Profasi human chorionic gonadotropin (hCG) The body produces two types of gonadotropins: follicle-stimulating hormone (FSH) and...
C:\Data\My Documents\My Documents\MERCIER\NDAS\LETTERS\20582s6ap.\ doc The intrinsic luteinizing hormone (LH) activity in follitropin beta is less than 1 IU per 40,000 IU FSH Humegon Without Pituitary Suppression With a GnRH...
author: Jennifer L. Mercier
Puregon, INN-Follitropin beta EPAR CPMP/ 003/ 96 1/ 12 EMEA 2000 SCIENTIFIC DISCUSSION Name of the medicinal product: Puregon Marketing Authorisation Holder: N. V. Organon P. O. Box 20 5340 BH Oss The Netherlands Active substance: Follitropin beta International Nonproprietary Name: Follitropin beta Pharmaco- therapeutic group ...
author: CPMP
subject: EPAR
THE MERCK MANUAL, Sec. 18, Ch. 245, Infertility This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 18.
THE MERCK MANUAL, Sec. 18, Ch. 245, Infertility This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 18LH) excretion 24 to 36 h before ovulation
http://www.fda.gov/cder/foi/label/1999/21047lbl.pdf RepronexO is biologically standardized for FSH and LH (ICSH) gonadotropin activities in terms of the Second International Reference Preparation for Human Menopausal Gonadotropins established in September, 1964 by the Expert Committee on Biological Standards of the World Health OrganizationFSH Pharmacokinetic Parameters* Upon Menotropins Administration...
http://www.fda.gov/cder/foi/label/1999/21047lbl.pdf page 2
http://www.fda.gov/cder/foi/label/1999/21047lbl.pdf page 1
http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
Prescription and OTC Drug Product List 10/2001 PEDIATRIC -D- + ASTRAZENECA 80MG/VIAL;0.02MG/VIAL;0.00 1MG/VIAL;5MG/VIAL;0.01MG/V IAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/ VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/V IAL N18920 001 SEP 21, 2000 OCT CAHN -A- + NEOSAN PHARMS 80MG/VIAL;0.02MG/VIAL;0.00 1MG/VIAL;5MG/VIAL;0.01MG/V IAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/ VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/V IAL...
FDA Drug Approvals List November 1999 Approvable Original New Drug Applications Original Application #: 020125 Approvable Date: 30-NOV-99 Trade Name: ACCURETIC Dosage Form: TABLET Applicant: PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO Active Ingredient(s): QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE OTC/RX Status: RX Original Abbreviated Application #: 075366 Tentative Approval Date: 02-NOV-99 Trade Name:...
Puregon, INN-Follitropin beta page 8 EPAR CPMP/ 003/ 96 8/ 12 EMEA 2000 37612 Efficacy and safety in Hypogonadal men (Humegoncompared) Randomise d, doubleblind, group comparativ e multientre study in hypopituita ry men 4 men (Puregon) 2 man (Humegon) Hypopituita ry men in good health with infertility characterist ics solvable by FSHtreatment ...
author: CPMP
subject: EPAR
Puregon, INN-Follitropin beta page 7 EPAR CPMP/ 003/ 96 7/ 12 EMEA 2000 Table 3 : overview of the efficacy and safety trials Study Type of study Study Design Number of patients Criteria for inclusion Dosage regimen Criteria for evaluation 37603 Efficacy and safety in IVF with various pituitary suppression regimens Open single centre pilot ...
author: CPMP
subject: EPAR
